CN-470

N/A

Report date: 2023/05/22 10:19:17
NME

Base Information

Drug NameCN-470
Drug Alias NameCN-470
ClassificationSmall molecules
Mechanisms of ActionBromodomain and extra terminal domain protein inhibitorscAMP-response element binding protein inhibitors
TargetsBromodomain and extra terminal domain proteincAMP-response element binding protein
Therapy Area/IndicationsPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKyoto Pharmaceutical University
China Registration ClassN/A

Develop Information

Active CompaniesKyoto Pharmaceutical University
Inactive CompaniesN/A
Active IndicationsPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A